Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1980-01-07
1981-08-25
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Lymphokine
435 68, 435811, A61K 4502, A61K 3900
Patent
active
042859298
ABSTRACT:
The present invention relates to processes which are easily applicable for industrial production of Type II interferon and Type II interferon-containing agents.
Particularly, the present processes are based on the invention that a large amount of high-titred Type II interferon is easily obtainable by transplanting established human cells in other warm-blooded animal body or inoculating the cells in a culture medium charged in a filter-membrane-interposed diffusion chamber which is designed and fitted in or to the animal body so that the cells can grow on its nutrient body fluid, multiplying the transplanted or inoculated cells in the warm-blooded animal body or the diffusion chamber utilizing the body fluid, then exposing the multiplied cells to the action of a Type II interferon inducer in vivo or in vitro to induce Type II interferon, and purifying and separating the induced Type II interferon. The agents containing Type II interferon obtained by the method disclosed herein are effective and superior for treating and preventing Type II interferon-sensitive diseases.
REFERENCES:
Chemical Abstracts, vol. 82, p. 352, Abstract No. 1462v, Anjinsen et al., "Partial Purification of Human Interferon by Affinity Chromatography", 1974.
Chemical Abstracts, vol. 89, p. 598, Abstract No. 105634a, Berthold et al., "Purification and In Vitro Labeling of Interferon From a Human Fibroblastoid Cell Line", 1978.
Chemical Abstracts, vol. 83, p. 334, Abstract No. 25879v, Borecky et al., "Stimulation of Interferon Production in Macrophages", 1975.
Miyoshi, I., et al., Cancer, vol. 40, pp. 2999-3003, 1977.
Dianzani, F., et al., Advances in Experimental Medicine and Biology, vol. 110, pp. 119-131, 1978.
Klein, G., et al., "Sensitivity of Epstein-Barr Virus (EBV) Producer and Non-Producer Human Lymphoblastoid Cell Lines to Superinfection with E.B. Virus", Int. J. Cancer, 10, 44-57, (1972).
J.L.M., "Current and Future Sources of Interferon", Science, vol. 204, pp. 1184-1185, Jun. 15, 1979.
Epstein, L. B. "Mitogen and Antigen Induction of Interferon In Vitro and In Vivo", Texas Reports on Biology and Medicine, vol. 35, 1977, pp. 42-56.
Chemical Abstracts, vol. 81, p. 391, Abst. No. 167513d, Sano et al., "Production of Mouse Interferon . . . ", 1974.
Chemical Abstracts, vol. 79, p. 298, Abst. No. 90455k, Tovey et al., "Production of Interferon . . . ", 1973.
Chemical Abstracts, vol. 74, p. 190, Abst. No. 21415g, Khesin et al., "Cytological Study of a Peritoneal . . . ", 1971.
Chemical Abstracts, vol. 89, p. 382, Abst. No. 88763r, Zavetskii et al., "Matrix Synthesis of Mouse Interferon . . . ", 1978.
De Maeyer-Guignard, J., "Mouse Leukemia: Depression of Serum Interferon Production", Science, vol. 177, pp. 797-799, (1972).
Sata, J., "The Current Situation of the Maintenance and Duration of Tissue Culture Cell Lines in Japan", Protein, Nucleic Acid and Enzyme; vol. 20, No. 4, pp. 616-643, (1975).
Strander, H., et al., "Production of Human Lymphoblastoid Interferon", Journal of Clinical Microbiology, vol. 1, No. 1, 116-117, Jan. 1975.
Miyoshi, I., et al., "Human B Cell, T Cell and Null Cell Leukaemic Cell Liner Derived from Acute Lymphoblastic Leukaemiai", Nature, vol. 267, No. 5614, pp. 843-844, Jun. 30, 1977.
Interferon, by S. Kobayashi, Kodansha, Ltd., Tokyo, Japan, 1975.
Interferon and its Clinical Potential, by D. H. J Tyrell, William Heinemann Medical Books, Ltd., London, 1976.
Protein, Nucleic Acid and Enzyme, vol. 21, No. 4, (1976), "Interferon-Problems Concerning its Application".
Sugimoto Kaname
Yuen Shokichi
Ashida Shin
Hayashibara Ken
Hazel Blondel
Phillips Delbert R.
LandOfFree
Type II interferon and agents thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Type II interferon and agents thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Type II interferon and agents thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1158267